Making your innovative cardiovascular drug a success

G-CURE aims to become a global scientific leader in the development of new (pharmacological) treatments for cardiovascular diseases with a focus on heart failure, preservation of left ventricular function after acute myocardial infarction and atrial fibrillation. We offer our unique skill sets and combined expertise to pharmaceutical, biotech and related industries, with services ranging from experimental animal studies to the creation of marketing authorisation dossiers.


Originating from the Department of Cardiology at the University Medical Center Groningen, G-CURE has a long-standing history of high quality scientific output in international cardiovascular research.

Overall focus area is the preservation of left ventricular function, with special interest in heart failure, atrial fibrillation and ischemic heart disease.


G-CURE offers you the unique opportunity to exploit its vast network of experienced and well-established partners in every aspect of drug development.

Your choice for G-CURE is a choice for top quality service providers in the fields of regulatory, preclinical and clinical study execution, data management and (expert) report writing.


G-CURE and its partners operate with state of the art technology, which will foster rapid generation of high quality data that comply with all international quality standards.

Choosing G-CURE will allow you to collect frontline scientific data that will maximize insight into the details of your product and help you take successful decisions.